Distinctive features of CD4+ T cell dysfunction in chronic viral infections

Current Opinion in HIV and AIDS

Volumn 9, Issue 5, 2014, Pages 446-451

  Morou, Antigoni ^a   Palmer, Brent E ^b   Kaufmann, Daniel E ^a,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

HIV; inhibitory coreceptors; lineage differentiation; T cell exhaustion

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN; T CELL IMMUNOGLOBULIN MUCIN 3; UNCLASSIFIED DRUG;

CD4+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE DYSFUNCTION; CD8+ T LYMPHOCYTE; CELL FATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; LYMPHOCYTE DIFFERENTIATION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE ACTIVATION; UPREGULATION; CHRONIC DISEASE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION;

EID: 84906056552     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000094     Document Type: Review

References (67)

1. Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell 2009; 138:30-50.
2. Matloubian M, Concepcion RJ, Ahmed R. CD4\+ T cells are required to sustain CD8\+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994; 68:8056-8063. (Pubitemid 24362694)
3. Zajac AJ, Blattman JN, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998; 188:2205-2213. (Pubitemid 29028493)
4. Aubert RD, Kamphorst AO, Sarkar S, et al. Antigen-specific CD4 T-cell help rescues exhausted CD8\+ T cells during chronic viral infection. Proc Natl Acad Sci USA 2011; 108:21182-21187.
5. Komanduri KV, Viswanathan MN, Wieder ED, et al. Restoration of cytomegalovirus-specific CD4\+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998; 4:953-956. (Pubitemid 28364037)
6. Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, et al. Broadly directed virus-specific CD4\+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med 2012; 209:61-75.
7. Theze J, Chakrabarti LA, Vingert B, et al. HIV controllers: A multifactorial phenotype of spontaneous viral suppression. Clin Immunol 2011; 141:15-30.
8. Walker BD, Yu XG. Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol 2013; 13:487-498.
9. Tubo NJ, Pagan AJ, Taylor JJ, et al. Single naive CD4\+ T cells from a diverse repertoire produce different effector cell types during infection. Cell 2013; 153:785-796.
10. Schietinger A, Greenberg PD. Tolerance and exhaustion: Defining mechanisms of T cell dysfunction. Trends Immunol 2014; 35:51-60.
11. Wherry EJ, Ha SJ, Kaech SM, et al. Molecular signature of CD8\+ T cell exhaustion during chronic viral infection. Immunity 2007; 27:670-684. (Pubitemid 47615511)
12. Scharer CD, Barwick BG, Youngblood BA, et al. Global DNA methylation remodeling accompanies CD8\+ T cell effector function. J Immunol 2013; 191:3419-3429.
13. Su LF, Kidd BA, Han A, et al. Virus-specific CD4(\+) memory-phenotype T cells are abundant in unexposed adults. Immunity 2013; 38:373-383.
14. Welsh RM, Che JW, Brehm MA, Selin LK. Heterologous immunity between viruses. Immunol Rev 2010; 235:244-266.
15. Wherry EJ. T cell exhaustion. Nat Immunol 2011; 12:492-499.
16. Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366:2443-2454.
17. Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366:2455-2465.
18. Hamid O, Robert C, Daud A, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013; 369:134-144.
19. Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med 2013; 369:122-133.
20. Kaufmann DE, Walker BD. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 2009; 182:5891-5897.
21. Blackburn SD, Shin H, Haining WN, et al. Coregulation of CD8\+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009; 10:29-37.
22. Kao C, Oestreich KJ, Paley MA, et al. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8\+ T cell responses during chronic infection. Nat Immunol 2011; 12:663-671.
23. Lu P, Youngblood BA, Austin JW, et al. Blimp-1 represses CD8\+ T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection. J Exp Med 2014; 211:515-527.
24. Quigley M, Pereyra F, Nilsson B, et al. Transcriptional analysis of HIV-specific CD8\+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med 2010; 16:1147-1151.
25. Doering TA, Crawford A, Angelosanto JM, et al. Network analysis reveals centrally connected genes and pathways involved in CD8\+ T cell exhaustion versus memory. Immunity 2012; 37:1130-1144.
26. Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIVspecific CD4\+ T cells. Nature 2002; 417:95-98. (Pubitemid 34498823)
27. Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4(\+) T cells in immunity to viruses. Nat Rev Immunol 2012; 12:136-148.
28. Morrison PJ, Bending D, Fouser LA, et al. Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation. Mucosal Immunol 2013; 6:1143-1156.
29. O'Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4\+ T cells. Science 2010; 327:1098-1102.
30. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010; 20:4-12.
31. Crotty S. The 1-1-1 fallacy. Immunol Rev 2012; 247:133-142.
32. Kanno Y, Vahedi G, Hirahara K, et al. Transcriptional and epigenetic control of T helper cell specification: Molecular mechanisms underlying commitment and plasticity. Ann Rev Immunol 2012; 30:707-731.
33. Evans CM, Jenner RG. Transcription factor interplay in T helper cell differentiation. Brief Funct Genomics 2013; 12:499-511.
34. Brooks DG, Teyton L, Oldstone MB, McGavern DB. Intrinsic functional dysregulation of CD4\+ T cells occurs rapidly following persistent viral infection. J Virol 2005; 79:10514-10527. (Pubitemid 41098591)
35. Brooks DG, Trifilo MJ, Edelmann KH, et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006; 12:1301-1309. (Pubitemid 44706933)
36. Ejrnaes M, Filippi CM, Martinic MM, et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 2006; 203: 2461-2472. (Pubitemid 44664616)
37. Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science 2009; 324:1569-1572.
38. Frohlich A, Kisielow J, Schmitz I, et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009; 324:1576-1580.
39. Fahey LM, Wilson EB, Elsaesser H, et al. Viral persistence redirects CD4\+ T cell differentiation toward T follicular helper cells. J Exp Med 2011; 208:987-999.
40. Chevalier MF, Julg B, Pyo A, et al. HIV-1-specific interleukin-21\+ CD4\+ T cell responses contribute to durable viral control through the modulation of HIVspecific CD8\+ T cell function. J Virol 2010; 85:733-741.
41. Brooks DG, McGavern DB, Oldstone MB. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest 2006; 116:1675-1685.
42. Krowka JF, Stites DP, Jain S, et al. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J Clin Invest 1989; 83:1198-1203. (Pubitemid 19113031)
43. Semmo N, Day CL, Ward SM, et al. Preferential loss of IL-2-secreting CD4\+T helper cells in chronic HCV infection. Hepatology 2005; 41:1019-1028. (Pubitemid 40593910)
44. Iyasere CA, Tilton JC, Johnson AJ, et al. Diminished proliferation of human immunodeficiency virus-specific CD4\+ T cell is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol 2003; 77:10900-10909. (Pubitemid 37204283)
45. Younes SA, Yassine-Diab B, Dumont AR, et al. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4\+ T cells endowed with proliferative capacity. J Exp Med 2003; 198:1909-1922. (Pubitemid 38032123)
46. Palmer BE, Boritz E, Wilson CC. Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4\+ T cell maturation and function. J Immunol 2004; 172:3337-3347. (Pubitemid 38263726)
47. Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8\+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061-1068. (Pubitemid 35363659)
48. Tilton JC, Luskin MR, Johnson AJ, et al. Changes in paracrine interleukin-2 requirement,CCR7expression, frequency,andcytokinesecretion, ofHIV-specificCD4\+T cells are a consequence of antigen load. J Virol 2006; 2713-2725. (Pubitemid 46447036)
49. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: Immune complex relations. Lancet Infect Dis 2005; 5:227-236. (Pubitemid 40410068)
50. Cubas RA, Mudd JC, Savoye AL, et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med 2013; 19:494-499.
51. Perreau M, Savoye AL, De Crignis E, et al. Follicular helper T cells serve as the major CD4\+ T cell compartment for HIV-1 infection, replication, and production. J Exp Med 2013; 210:143-156.
52. Boswell KL, Paris R, Boritz E, et al. Loss of circulating CD4\+ T cells with B cell helper functionduringchronicHIVinfection.PLoSPathog2014;10:e1003853.
53. Lindqvist M, van Lunzen J, Soghoian DZ, et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 2012; 122:3271-3280.
54. Kaufmann DE, Kavanagh DG, Pereyra F, et al. Upregulation of CTLA-4 by HIVspecific CD4\+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007; 8:1246-1254. (Pubitemid 350011764)
55. D'Souza M, Fontenot AP, Mack DG, et al. Programmed death 1 expression on HIV-specific CD4\+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol 2007; 179:1979-1987.
56. Porichis F, Kwon DS, Zupkosky J, et al. Responsiveness of HIV-specific CD4\+ T cells to PD-1 blockade. Blood 2011; 118:965-974.
57. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-354. (Pubitemid 44435155)
58. Porichis F, Hart MG, Zupkosky J, et al. In vitro assay to evaluate the impact of immunoregulatory pathways on HIV-specific CD4\+ T cell effector function. J Vis Exp 2013; e50821.
59. Frahm N, Kaufmann DE, Yusim K, et al. Increased sequence diversity coverage improves detection of HIV-specific T cell responses. J Immunol 2007; 179:6638-6650.
60. Kassu A, Marcus RA, D'Souza MB, et al. Regulation of virus-specific CD4\+ T cell function by multiple costimulatory receptors during chronic HIV infection. J Immunol 2010; 185:3007-3018.
61. Dow C, Henderson R, Sette A, Mothe BR. CD4(\+) T-cell inhibitory ligands: A tool for characterizing dysfunctional CD4(\+) T cells during chronic infection. Immunology 2013; 140:61-69.
62. Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4\+ T cell activation during HIV infection. Nat Med 2010; 16:452-459.
63. Brockman MA, Kwon DS, Tighe DP, et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009; 114:346-356.
64. Porichis F, Hart MG, Zupkosky J, et al. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4\+ T cell and antigen-presenting cell functions. J Virol 2014; 88:2508-2518.
65. Palmer BE, Neff CP, Lecureux J, et al. In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4\+ T cell levels in humanized mice. J Immunol 2013; 190:211-219.
66. Seung E, Dudek TE, Allen TM, et al. PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads. PLoS One 2013; 8:e77780.
67. Crawford A, Angelosanto JM, Kao C, et al. Molecular and transcriptional basis of CD4(\+) T cell dysfunction during chronic infection. Immunity 2014; 40:289-302.